Your browser doesn't support javascript.
loading
Point-of-care diagnostics for infection and antimicrobial resistance in sub-Saharan Africa: A narrative review.
Hermans, Lucas Etienne; Centner, Chad M; Morel, Chantal M; Mbamalu, Oluchi; Bonaconsa, Candice; Ferreyra, Cecilia; Lindahl, Olof; Mendelson, Marc.
Afiliación
  • Hermans LE; Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: luukje@gmail.com.
  • Centner CM; Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
  • Morel CM; Department of Business Studies, Uppsala University, Uppsala, Sweden; Institute for Hygiene and Public Health, Bonn University Hospital, Bonn, Germany; University of Bern, KPM Center for Public Management, Bern, Switzerland.
  • Mbamalu O; Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Bonaconsa C; Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Ferreyra C; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
  • Lindahl O; Department of Business Studies, Uppsala University, Uppsala, Sweden.
  • Mendelson M; Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Int J Infect Dis ; 142: 106907, 2024 May.
Article en En | MEDLINE | ID: mdl-38141961
ABSTRACT

OBJECTIVES:

Sub-Saharan African (SSA) countries are severely impacted by antimicrobial resistance (AMR). Due to gaps in access to diagnostics in SSA, the true extent of AMR remains unknown. This diagnostic gap affects patient management and leads to significant antimicrobial overuse. This review explores how point-of-care (POC) testing for pathogen identification and AMR may be used to close the diagnostic gap in SSA countries.

METHODS:

A narrative review exploring current clinical practice and novel developments in the field of POC testing for infectious diseases and AMR.

RESULTS:

POC assays for identification of various pathogens have been successfully rolled out in SSA countries. While implementation studies have mostly highlighted impressive test performance of POC assays, there is limited data on the impact of implementation on clinical outcomes and cost-effectiveness. We did not encounter local studies of host-directed POC assays relevant to AMR. Novel POC assays using real-time polymerase chain reaction, isothermal amplification, microfluidics, and other technologies are in various stages of development.

CONCLUSIONS:

Available literature shows that POC testing for AMR applications is implementable in SSA and holds the potential to reduce the diagnostic gap. Implementation will require effective regulatory pathways, incorporation of POC testing in clinical and laboratory guidelines, and adequate value capture in existing health financing models.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antiinfecciosos / Antibacterianos Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antiinfecciosos / Antibacterianos Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article